Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07418905 · ClinicalTrials.gov registry record · NA

Technology-supported Motor Rehabilitation for People With Rett Syndrome

A NA study of Rett Syndrome, sponsored by Georgetown University.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT07418905: Active NA study of Rett Syndrome, sponsored by Georgetown University.

NCT07418905 is a NA study of Rett Syndrome that is active but no longer recruiting, run by Georgetown University. The registered enrollment target is 14 participants, below the 525-participant average among 18 other Rett Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07418905, a NA study of Rett Syndrome, is active but no longer recruiting, sponsored by Georgetown University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This study focuses on improving purposeful arm use while simultaneously reducing engagement in stereotypies. It is typically expected that the training period for this study will last about 6 months. The first half of the training periods will be devoted to learning to separate hands to stop the stereotypies that interfere with arm and hand use. In this first half, participants will also need to learn to keep arms apart in order to be actively involved in the chosen game. The second half of the training period will be devoted to learning to stop stereotypies and reach for targets that are intended to start game play. When not touching the targets, the software will interpret that the game should stop and wait for the next target to be touched.

Primary Outcome

We will collect two variables: the number of times the participant engages in her unique stereotypy and the length of time (in seconds) that the stereotypy occurs. Data will be collected from both weekly intervention sessions and the two functional assessments. Functional data will be collected from the movements made by the individual as well as from BEFORE and AFTER questionnaires to be completed by the caregivers of the participant.

Conditions Studied

Interventions

  • BEHAVIORAL computer gaming

Study Locations (1)

Maryland

  • Georgetown University School of Medicine - Bethesda

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2024-10-01
Est. Completion 2026-07-31
Phase NA
Georgetown University

227 total trials

What the registry record for NCT07418905 still lists

NCT07418905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 525-participant average among 18 other Rett Syndrome trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Rett Syndrome appearing as the primary indexed condition, and to 1 intervention - of which computer gaming is the first listed.

NCT07418905 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT07418905 about?

NCT07418905 is a clinical study titled "Technology-supported Motor Rehabilitation for People With Rett Syndrome". This study focuses on improving purposeful arm use while simultaneously reducing engagement in stereotypies. It is typically expected that the training period for this study will last about 6 months. The first half of the training periods will be devoted to learning to separate hands to stop the ste...

What is the current status of trial NCT07418905?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2024-10-01. Estimated completion is 2026-07-31.

What conditions does trial NCT07418905 study?

This clinical trial studies the following conditions: Rett Syndrome.

What interventions are being tested in trial NCT07418905?

The interventions under investigation include: computer gaming (BEHAVIORAL).

Who is sponsoring clinical trial NCT07418905?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07418905 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rett Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07418905's enrollment target sits among peer trials

14 16th of 18 higher than 3 of 18 other Rett Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rett Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07418905, the US trial registry maintained by the National Library of Medicine. NCT07418905 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.